baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

INCYTE DL-,001/ US45337C1027 /

2024-11-08 7:30:41 PM	Chg. +2.22	Volume	Bid8:04:51 PM	Ask8:04:51 PM	Market Capitalization	Dividend Y.	P/E Ratio
77.34EUR	+2.96%	0 Turnover: 0.00	-Bid Size: -	-Ask Size: -	14.99 bill.EUR	-	-

GlobeNewswire 08-27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy

GlobeNewswire 08-16 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...

GlobeNewswire 08-06 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

GlobeNewswire 08-01 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update

GlobeNewswire 07-30 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...

Newsfile Corp 07-17 Analysts Hunt for Undervalued Biotech Stocks

TeleTrader 07-09 US closes mostly higher after Fed's chair testimony

GlobeNewswire 06-25 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...

GlobeNewswire 05-29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 05-28 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 05-09 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 04-30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 04-02 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 04-01 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 02-28 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 01-09 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 2023-12-12 Wall Street closes higher after inflation report

GlobeNewswire 2023-12-09 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 2023-11-16 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 2023-11-02 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 2023-10-23 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

GlobeNewswire 2023-10-12 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

GlobeNewswire 2023-09-27 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

INCYTE DL-,001/ US45337C1027 /

If you wish to receive reply to your feedback, please provide your email address.